Kennedy W. Mwai

1 Jan Smuts Avenue
Johannesburg, GT 2000, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Comparative performance of the InBios SCoV-2 Detect TM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations.

Comparative performance of the InBios SCoV-2 Detect TM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations.

Journal: Wellcome open research

Published: July 25, 2025

Baseline Treg frequency, Treg-associated immune checkpoint responses, and plasma IL-10 responses during controlled human malaria infection in semi-immune Kenyan adults: a secondary analysis of the CHMI-SIKA Study.

Baseline Treg frequency, Treg-associated immune checkpoint responses, and plasma IL-10 responses during controlled human malaria infection in semi-immune Kenyan adults: a secondary analysis of the CHMI-SIKA Study.

Journal: The Lancet. Microbe

Published: April 22, 2025

Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunity.

Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunity.

Journal: Nature communications

Published: March 24, 2025

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study.

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study.

Journal: Wellcome open research

Published: November 26, 2024

Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.

Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.

Journal: The Journal of infection

Published: June 12, 2024

Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.

Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.

Journal: Immunity

Published: January 30, 2024

Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites.

Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites.

Journal: Frontiers in immunology

Published: December 22, 2023

Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.

Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.

Journal: Frontiers in immunology

Published: November 20, 2023

Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.

Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.

Journal: Science translational medicine

Published: February 08, 2023

Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target.

Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target.

Journal: Frontiers in immunology

Published: February 01, 2023

Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.

Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.

Journal: Life science alliance

Published: January 08, 2023

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro.

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: September 06, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026